Pfizer Q4 2025: Strong Performance Despite COVID Decline
Pfizer beats Q4 estimates with $17.6B revenue as legacy drugs offset COVID sales drop. Obesity drug shows 12.3% weight loss. 2026 guidance reaffirmed.
Pfizer beats Q4 estimates with $17.6B revenue as legacy drugs offset COVID sales drop. Obesity drug shows 12.3% weight loss. 2026 guidance reaffirmed.
PayPal (PYPL) announces CEO change as Q4 earnings disappoint. HP's Enrique Lores to replace Alex Chriss. Shares drop 16% on weak retail spending and slowing branded checkout growth.
BofA analyst upgrades Sigma Lithium to Neutral as mining activities resume, reducing timeline risks but liquidity concerns remain.
Morgan Stanley upgraded Affirm to Overweight, saying recent stock weakness offers a compelling risk/reward and long-term growth remains intact.
JPMorgan upgraded SoFi to Overweight after a stock dip, saying strong growth, record results, and rising members make this a key entry point.
BlackRock’s Global Infrastructure Partners and EQT are in talks to buy AES Corp., a major power company supplying renewable energy to tech giants like Microsoft.